More than half of U.S. cancer patients now receive treatment in community settings, reflecting major shifts in both science and care delivery. In this episode of The Top Line, Kirk Kaminsky, executive vice president and group president of North American Pharmaceutical Services for McKesson, explains why community oncology has become a cornerstone of modern cancer care. As diagnoses grow more precise and patients live longer with cancer, care delivered closer to home offers meaningful benefits for patients and the health care system.
Kaminsky describes how the rapid pace of innovation is reshaping community practices, creating new demands related to reimbursement and operations. He outlines how McKesson and The US Oncology Network support providers with technology, administrative services and patient-focused resources, allowing oncologists to spend more time delivering care and less time managing complexity.
The discussion also highlights the expanding role of community oncology in clinical trials and the use of artificial intelligence to streamline workflows and reduce administrative burden. Kaminsky shares his perspective on what lies ahead for cancer care and why continued investment in community practices will be essential. Listen to the full interview to hear his insights.